Physician

Elizabeth A Wetzel, DO

According to 2025 Medicare claims, Elizabeth Wetzel, DO (NPI: 1881634566) practices family practice in the South Bend-Mishawaka, IN-MI market, with the plurality of this provider's patient population coming from Cass, MI. This provider's primary affiliated billing organization is LAKELAND IMMEDIATE CARE CENTER (NPI: 1982677548; TIN: 383082107) and primary practice location at 49031-1034. Wetzel is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Wetzel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 45 traditional Medicare patients, billed 88 HCPCS/CPT codes, and received $1,184 in Medicare payments. The top billing code was 83036 (Hemoglobin a1c level). Part D data shows 8,925 prescription claims across 520 beneficiaries totaling $778,001 in drug costs, led by Jardiance (Empagliflozin). DME data shows 194 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $661 and ending at $1,184. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $169,565 to $778,001. For DME billing, reported payments started with an early spike, then settled into a lower baseline, moving from $24,008 to $9,189.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	55	77	$661
2016	94	131	$981
2017	39	48	$374
2018	72	81	$335
2019	85	92	$281
2020	56	62	$250
2021	55	69	$390
2022	53	85	$817
2023	51	77	$628
2024	45	88	$1,184

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	355	3,034	$169,565
2016	361	4,849	$310,839
2017	417	5,640	$336,696
2018	473	8,050	$514,664
2019	611	9,290	$695,408
2020	524	9,035	$713,437
2021	415	7,950	$715,638
2022	484	8,506	$743,464
2023	517	9,569	$948,271
2024	520	8,925	$778,001

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	67	398	$20,953
2016	41	297	$7,795
2017	35	209	$3,253
2018	41	245	$5,237
2019	71	324	$13,561
2020	42	345	$12,596
2021	37	223	$4,463
2022	21	216	$20,580
2023	18	213	$18,656
2024	15	194	$16,097

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
83036	Hemoglobin a1c level	25	46	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	92	6,020	$116,251
Mounjaro	Tirzepatide	69	2,044	$76,105
Eliquis	Apixaban	62	3,195	$58,764
Ozempic	Semaglutide	48	2,048	$58,707
Trulicity	Dulaglutide	50	1,680	$55,882

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,154
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	43	$2,789
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	12	$1,887
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	11	$596
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	15	37	$389

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Elizabeth A. Wetzel, DO?

Tedicare shows public-source Medicare data for Elizabeth A. Wetzel, DO (NPI 1881634566), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Elizabeth A. Wetzel, DO have ACO affiliation data?

Elizabeth A. Wetzel, DO is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Elizabeth A. Wetzel, DO?

Elizabeth A. Wetzel, DO is linked to LAKELAND IMMEDIATE CARE CENTER (billing NPI 1982677548) in the available physician profile data.

Does Elizabeth A. Wetzel, DO have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.